European Commission approves nivolumab plus ipilimumab combination for first-line advanced RCC
The European Commission has approved the nivolumab plus ipilimumab combination [...]
Pros and cons of lymph node dissection at the time of nephrectomy
The following two presentations were given at the Canadian Uro-oncology [...]
Biopsy of small renal masses – still controversial?
Dr Finelli from the Princess Margaret Cancer Centre in Toronto, [...]
Real world evidence as a complement to clinical trials
The review article highlights the usefulness of real world evidence [...]
Personalised vaccine to be tested in patients with kidney cancer
Scientists at the Dana-Farber Cancer Institute in Boston, USA, are [...]
NHS Long Term Plan launched today
The new NHS Long Term Plan is published today with [...]
Breath test for cancer enters clinical trials
Cancer Research UK are pioneering a potential breath test for [...]
Prognosis of kidney cancer patients with bone metastases
A recent study published in the European Journal of Cancer [...]
Kidney stones associated with an increased risk of kidney cancer
A recent study involving 5,000 patients from The Netherlands who [...]
Current role of mTOR inhibitors in metastatic kidney cancer
The following video interview with Dr Eric Jonasch, from the [...]
